Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cavernous angioma: a clinical study of 35 cases with review of the literature.
Intra- and interscanner variability of magnetic resonance imaging based volumetry in multiple sclerosis.
Celastrol and Its Role in Controlling Chronic Diseases.
Nurse led telephone assessment of expanded disability status scale assessment in MS patients at high levels of disability.
CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: too big to fail?
Exploring cognitive reserve in multiple sclerosis: New findings from a cross-sectional study.
Dopamine characteristics in different rat genotypes: the relation to absence epilepsy.
Effects of motor-motor and motor-cognitive tasks on balance in patients with multiple sclerosis.
Development of the multiple sclerosis (MS) early mobility impairment questionnaire (EMIQ).
Is It worth Considering Circulating microRNAs in Multiple Sclerosis?
The Cost of Relapsing-Remitting Multiple Sclerosis Patients Who Develop Neutralizing Antibodies during Interferon Beta Therapy.
Neurological antiphospholipid syndrome: Clinical, neuroimaging, and pathological characteristics.
Thoracic sensory level as a false localizing sign in cervical spinal cord and brain lesions.
CellCept Drug Details
Clinical implications of neuroplasticity - the role of rehabilitation in multiple sclerosis.
Anti-Inflammatory and Antioxidant Mechanism of Tangeretin in Activated Microglia.
Key players in neurodegenerative disorders in focus - new insights into the proteomic profile of Alzheimer`s disease, schizophrenia, ALS and multiple sclerosis - 24th HUPO BPP Workshop: 29 September 2015, Vancouver, Canada.
Simultaneous early-onset immune thrombocytopenia and autoimmune thyroid disease following alemtuzumab treatment in relapsing-remitting multiple sclerosis.
Multiple sclerosis and amyotrophic lateral sclerosis: is there a link?
Editorial: Single membrane channels formed by connexins or pannexins: focus on the nervous system.
BK virus encephalopathy and sclerosing vasculopathy in a patient with hypohidrotic ectodermal dysplasia and immunodeficiency.
Radiosurgery for Secondary Trigeminal Neuralgia: Revisiting the Treatment Paradigm.
Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis.
Distinct Clinical Characteristics of Pediatric Guillain-Barré Syndrome: A Comparative Study between Children and Adults in Northeast China.
Pages
« first
‹ previous
…
724
725
726
727
728
729
730
731
732
…
next ›
last »